Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Psychiatry
Volume 2017 (2017), Article ID 1364894, 7 pages
https://doi.org/10.1155/2017/1364894
Case Report

Adult ADHD: Questioning Diagnosis and Treatment in a Patient with Multiple Psychiatric Comorbidities

1Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada
2Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada

Correspondence should be addressed to Zainab Samaan

Received 9 January 2017; Revised 19 April 2017; Accepted 30 April 2017; Published 11 June 2017

Academic Editor: Toshiya Inada

Copyright © 2017 Robert Karoly Chu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Paris, V. Bhat, and B. Thombs, “Is adult attention-deficit hyperactivity disorder being overdiagnosed?” Canadian Journal of Psychiatry, vol. 60, no. 7, pp. 324–328, 2015. View at Google Scholar · View at Scopus
  2. M. Candy, L. Jones, R. Williams, A. Tookman, and M. King, “Psychostimulants for depression.,” Cochrane database of systematic reviews (Online), no. 2, p. CD006722, 2008. View at Google Scholar · View at Scopus
  3. M. Olfson, C. Blanco, S. Wang, and L. L. Greenhill, “With stimulants in the United States,” Journal of Clinical Psychiatry, vol. 74, no. 1, pp. 43–50, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. S. McCarthy, L. Wilton, M. L. Murray, P. Hodgkins, P. Asherson, and I. C. K. Wong, “The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care,” BMC Pediatrics, vol. 12, article no. 78, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. APA, “Diagnostic and statistical manual of mental disorders,” in A.P. Association, American Psychiatric Publishing, Arlington, VA, 5th edition, 2013. View at Google Scholar
  6. A. J. Rush, M. H. Trivedi, S. R. Wisniewski et al., “Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STARD report,” The American Journal of Psychiatry, vol. 163, no. 11, pp. 1905–1917, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. APA, “Diagnostic and statistical manual of mental disorders,” in A.P. Association, American Psychiatric Publishing, Washington, DC, 4th edition, 2000. View at Google Scholar
  8. S. J. J. Kooij, S. Bejerot, A. Blackwell et al., “European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD,” BMC Psychiatry, vol. 10, article no. 67, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. L. A. Adler and H. C. Chua, “Management of ADHD in adults,” Journal of Clinical Psychiatry, vol. 63, 12, pp. 29–35, 2002. View at Google Scholar
  10. P. Asherson, W. Chen, B. Craddock, and E. Taylor, “Adult attention-deficit hyperactivity disorder: Recognition and treatment in general adult psychiatry,” British Journal of Psychiatry, vol. 190, pp. 4-5, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Castells, J. A. Ramos-Quiroga, R. Bosch, M. Nogueira, and M. Casas, “Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults,” Cochrane database of systematic reviews (Online), no. 6, p. CD007813, 2011. View at Google Scholar · View at Scopus
  12. NICE, “Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults,” National Institute for Health and Clinical Excellence, 2008, Clinical guideline 72. http://www.nice.org.uk/CG72. View at Google Scholar
  13. R. H. Weisler, “Safety, efficacy and extended duration of action of mixed amphetamine salts extended-release capsules for the treatment of ADHD,” Expert Opinion on Pharmacotherapy, vol. 6, no. 6, pp. 1003–1017, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Richieri, M. Adida, L. Boyer, and C. Lançon, “Psychostimulants in the treatment of depression,” Presse Medicale, vol. 42, no. 3, pp. 347–352, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. M. T. Berlim and G. Turecki, “Using psychostimulants for treating residual symptoms in major depression,” Journal of Psychiatry and Neuroscience, vol. 32, no. 4, p. 304, 2007. View at Google Scholar · View at Scopus
  16. R. H. Weisler, J. Biederman, T. J. Spencer, and T. E. Wilens, “Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD,” CNS Spectrums, vol. 10, no. 12, pp. 35–43, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. R. H. Weisler, J. Biederman, T. J. Spencer et al., “Mixed amphetamine salts extended-release in the treatment of adult ADHD: A randomized, controlled trial,” CNS Spectrums, vol. 11, no. 8, pp. 625–639, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. P. J. Carlson, M. C. Merlock, and T. Suppes, “Adjunctive stimulant use in patients with bipolar disorder: Treatment of residual depression and sedation,” Bipolar Disorders, vol. 6, no. 5, pp. 416–420, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. U. Hegerl, C. Sander, S. Olbrich, and P. Schoenknecht, “Are psychostimulants a treatment option in mania?” Pharmacopsychiatry, vol. 42, no. 5, pp. 169–174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Orr and D. Taylor, “Psychostimulants in the treatment of depression: A review of the evidence,” CNS Drugs, vol. 21, no. 3, pp. 239–257, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Ashton, P. Gallagher, and B. Moore, “The adult psychiatrist's dilemma: Psychostimulant use in attention deficit/hyperactivity disorder,” Journal of Psychopharmacology, vol. 20, no. 5, pp. 602–610, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. S. H. Kollins, J. English, R. Robinson, M. Hallyburton, and A. K. Chrisman, “Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD),” Psychopharmacology, vol. 204, no. 1, pp. 73–83, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. S. H. Kollins, “Comparing the abuse potential of methylphenidate versus other stimulants: A review of available evidence and relevance to the ADHD patient,” Journal of Clinical Psychiatry, vol. 64, 11, pp. 14–18, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. S. H. Kollins, E. K. MacDonald, and C. R. Rush, “Assessing the abuse potential of methylphenidate in nonhuman and human subjects : A review,” Pharmacology Biochemistry and Behavior, vol. 68, no. 3, pp. 611–627, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. A.-L. Pélissier-Alicot, M.-D. Piercecchi-Marti, C. Bartoli et al., “Abusive prescription of psychostimulants: A study of two cases,” Journal of Forensic Sciences, vol. 51, no. 2, pp. 407–410, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. S. P. Novak, L. A. Kroutil, R. L. Williams, and D. L. Van Brunt, “The nonmedical use of prescription ADHD medications: Results from a national Internet panel,” Substance Abuse: Treatment, Prevention, and Policy, vol. 2, no. 1, article no. 32, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Cascade, A. H. Kalali, and R. H. Weisler, “Short-acting versus long-acting medications for the treatment of adhd,” Psychiatry (Edgmont), vol. 5, no. 8, pp. 24–27, 2008. View at Google Scholar
  28. A. Cleare, C. M. Pariante, A. H. Young et al., “Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines,” Journal of Psychopharmacology, vol. 29, no. 5, pp. 459–525, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Abbasowa, L. V. Kessing, and M. Vinberg, “Psychostimulants in moderate to severe affective disorder: A systematic review of randomized controlled trials,” Nordic Journal of Psychiatry, vol. 67, no. 6, pp. 369–382, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. C. H. Kellner, R. M. Greenberg, J. W. Murrough, E. O. Bryson, M. C. Briggs, and R. M. Pasculli, “ECT in treatment-resistant depression,” American Journal of Psychiatry, vol. 169, no. 12, pp. 1238–1244, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Parker, H. Brotchie, G. McClure, and K. Fletcher, “Psychostimulants for managing unipolar and bipolar treatment-resistant melancholic depression: A medium-term evaluation of cost benefits,” Journal of Affective Disorders, vol. 151, no. 1, pp. 360–364, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Sinita and D. Coghill, “The use of stimulant medications for non-core aspects of ADHD and in other disorders,” Neuropharmacology, vol. 87, pp. 161–172, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. A. V. Ravindran, S. H. Kennedy, M. C. O'Donovan, A. Fallu, F. Camacho, and C. E. Binder, “Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial,” Journal of Clinical Psychiatry, vol. 69, no. 1, pp. 87–94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. A. A. Patkar, P. S. Masand, C.-U. Pae et al., “A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression,” Journal of Clinical Psychopharmacology, vol. 26, no. 6, pp. 653–656, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. T. T. Postolache, R. N. Rosenthal, D. J. Hellerstein et al., “Early augmentation of sertraline with methylphenidate,” The Journal of Clinical Psychiatry, vol. 60, no. 2, pp. 123-124, 1999. View at Publisher · View at Google Scholar
  36. J. Caballero and M. C. Nahata, “Atomoxetine Hydrochloride for the Treatment of Attention-Deficit/ Hyperactivity Disorder,” Clinical Therapeutics, vol. 25, no. 12, pp. 3065–3083, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. G. I. Papakostas, T. J. Petersen, A. M. Burns, and M. Fava, “Adjunctive atomoxetine for residual fatigue in major depressive disorder,” Journal of Psychiatric Research, vol. 40, no. 4, pp. 370–373, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. T. R. Berigan, “Atomoxetine Used adjunctively with selective serotonin reuptake inhibitors to treat depression,” The Primary Care Companion to The Journal of Clinical Psychiatry, vol. 6, no. 2, pp. 93-94, 2004. View at Publisher · View at Google Scholar
  39. L. L. Carpenter, N. Milosavljevic, J. M. Schecter, A. R. Tyrka, and L. H. Price, “Augmentation with open-label atomoxetine for partial or nonresponse to antidepressants,” The Journal of Clinical Psychiatry, vol. 66, no. 10, pp. 1234–1238, 2005. View at Publisher · View at Google Scholar
  40. D. Michelson, L. A. Adler, J. D. Amsterdam et al., “Addition of atomoxetine for depression incompletely responsive to sertraline,” The Journal of Clinical Psychiatry, vol. 68, no. 4, pp. 582–587, 2007. View at Publisher · View at Google Scholar
  41. B. Ng, “Psychostimulants and treatment resistant depression: Letters to the editor,” Acta Psychiatrica Scandinavica, vol. 120, no. 6, pp. 502-503, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. B. Ng, “Is there a role for psychostimulants in old age depression and apathy?” International Psychogeriatrics, vol. 21, no. 2, pp. 417-418, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Arcand and P. Hottin, “The treatment of depression in the elderly. The use of psychostimulants,” Canadian Family Physician, vol. 39, pp. 2420–2426, 1993. View at Google Scholar · View at Scopus
  44. S. E. Hardy, “Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults,” American Journal Geriatric Pharmacotherapy, vol. 7, no. 1, pp. 34–59, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. C. W. Kerr, J. Drake, R. A. Milch et al., “Effects of methylphenidate on fatigue and depression: A randomized, double-blind, placebo-controlled trial,” Journal of Pain and Symptom Management, vol. 43, no. 1, pp. 68–77, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Olin and P. Masand, “Psychostimulants for depression in hospitalized cancer patients,” Psychosomatics, vol. 37, no. 1, pp. 57–62, 1996. View at Publisher · View at Google Scholar · View at Scopus
  47. J. C. Huffman and T. A. Stern, “Using psychostimulants to treat depression in the medically Ill,” The Primary Care Companion to The Journal of Clinical Psychiatry, vol. 06, no. 1, pp. 44–46, 2004. View at Publisher · View at Google Scholar
  48. G. Stotz, B. Woggon, and J. Angst, “Psychostimulants in the therapy of treatment-resistant depression review of the literature and findings from a retrospective study in 65 depressed patients,” Dialogues Clin Neurosci, vol. 1, no. 3, pp. 165–174, 1999. View at Google Scholar
  49. H. Lavretsky and A. Kumar, “Methylphenidate augmentation of citalopram in elderly depressed patients,” American Journal of Geriatric Psychiatry, vol. 9, no. 3, pp. 298–303, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Lavretsky, M. Reinlieb, N. S. Cyr, P. Siddarth, L. M. Ercoli, and D. Senturk, “Citalopram, methylphenidate, or their combination in geriatric depression: A randomized, double-blind, placebo-controlled trial,” American Journal of Psychiatry, vol. 172, no. 6, pp. 561–569, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Martinez-Raga, C. Knecht, N. Szerman, and M. I. Martinez, “Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder,” CNS Drugs, vol. 27, no. 1, pp. 15–30, 2013. View at Publisher · View at Google Scholar · View at Scopus